CRISPR/Cas9 Delivery Potentials in Alzheimer’s Disease Management: A Mini Review

Alzheimer’s disease (AD) is the most common dementia disorder. While genetic mutations account for only 1% of AD cases, sporadic AD resulting from a combination of genetic and risk factors constitutes >90% of the cases. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-associated...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanafy, Amira Sayed, Schoch, Susanne, Lamprecht, Alf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7559557/
https://www.ncbi.nlm.nih.gov/pubmed/32854251
http://dx.doi.org/10.3390/pharmaceutics12090801

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7559557/
https://www.ncbi.nlm.nih.gov/pubmed/32854251
http://dx.doi.org/10.3390/pharmaceutics12090801

Ejemplares similares